JNJ and PG both trade at 21x forward earnings, but J&J's 46% payout ratio versus P&G's 62% signals stronger long-term dividend coverage.
P&G carries a $1.4 billion after-tax earnings headwind into fiscal 2027, while J&J has already absorbed its Stelara biosimilar competition.
J&J's 10-year share price gain of 181% nearly doubled P&G's 117%, with management targeting double-digit earnings growth by decade's end.
Read More: Learn 7 ways to generate income with a $1,000,000+ portfolio (sponsor)
Johnson & Johnson (NYSE:JNJ) orProcter & Gamble (NYSE:PG): If someone saving for retirement could hold only one Dividend King for the next 20 years, which one should it be? My pick is Johnson & Johnson, and the gap is wider than the yields suggest. Both stocks trade near 21 times forward earnings (P&G at 21), so valuation is effectively a tie. The decision comes down to three things that matter more to a retiree: dividend coverage, durability and structural risk.

#trade

Broyhill **** et Management, a Charlotte-based firm, issued its second-quarter 2026 investor letter, which is available for download here. The Broyhill Equity Composite gained 8.8% in Q2, trailing the MSCI All Country World Index's 15.1% and the MSCI ACWI Value Index's 10.8%. For the first half, the Composite returned 2.3%, versus 11.5% for the Index. The letter highlights that a significant portion of the shortfall occurred in April due to market dynamics and geopolitical events, with tech, particularly semiconductors, driving recent gains. Broyhill notes its lack of direct semiconductor exposure but acknowledges potential interest in the sector if opportunities arise, maintaining its investment philosophy focused on capital protection in fragile market conditions. Also, check the fund's top five holdings to see its best picks in 2026.
In its second-quarter 2026 investor letter, Broyhill **** et Management highlighted Rentokil Initial plc (NYSE:RTO). Rentokil Initial plc (NYSE:RTO) is a route-based service provider that offers a range of pest control services. On September 14, 2026, Rentokil Initial plc (NYSE:RTO) closed at $22.55 per share. Over the past month, Rentokil Initial plc (NYSE:RTO) declined 5.34%, but its shares are down 10.61% over the past year. Rentokil Initial plc (NYSE:RTO) has a market capitalization of $11.2 billion, and its stock has traded within a 52-week range of $22.24 to $34.67.
Broyhill **** et Management stated the following regarding Rentokil Initial plc (NYSE:RTO) in its Q2 2026 investor letter:
"Rentokil Initial plc (NYSE:RTO) declined 9%. North American pest organic growth of 2.8% was entirely price, and customer retention remains near 80%. Our thesis is that the significant valuation discount to peer Rollins (almost half at the end of the second quarter) narrows as the Terminix integration is delivered."
Rentokil Initial plc (NYSE:RTO) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 15 hedge fund portfolios held Rentokil Initial plc (NYSE:RTO) at the end of the second quarter, compared to 19 in the previous quarter. While we acknowledge the potential of Rentokil Initial plc (NYSE:RTO) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

#quarter #letter #investor

Amgen Inc. (NASDAQ:AMGN) shed roughly $12 billion in market value after hours on September 4, 2026. The stock declined by about 5% to $415. The reason, as strange as it sounds, is a drug it does not own. Novartis announced that pelacarsen, an Lp(a)-lowering therapy, missed its Phase 3 cardiovascular-outcomes trial, Lp(a)HORIZON. And since Amgen's late-stage ******* et olpasiran relies on the same biological premise, investors immediately marked down Amgen on the negative read-through.
The result strikes at a premise rather than at a product. Pelacarsenhad lowered Lp(a) by roughly 80% in earlier studies. In Lp(a)HORIZON, Novartis said pelacarsen substantially lowered Lp(a), but it still failed to reduce the composite of cardiovascular death, heart attack, stroke, and urgent revascularization. It still could not reduce the composite of cardiovascular death, heart attack, stroke, and urgent revascularization. And now the entire hypothesis that lowering Lp(a), a genetic cardiovascular risk factor, actually cuts events, is being directly challenged. Olpasiran is built on the same hypothesis, leading to the repricing of odds as soon as pelacarsen's data were out.
Amgen's olpasiran, an siRNA, lowered Lp(a) by more than 95% at certain doses in Phase 2, compared with reductions of roughly 80% for pelacarsen in earlier studies. The bull case is that this deeper reduction could help olpasiran deliver better cardiovascular outcomes.. The bull case is that this 15% will help Amgen to make a deeper cut and deliver results. While biologically possible, the Lp(a)HORIZON trial provided no evidence that a clinical threshold exists above an 80% reduction. The topline Phase 3 announcement did not establish that deeper Lp(a) lowering would have produced a cardiovascular benefit. It is therefore appropriate to say that the miss lowered olpasiran's probability of success rather than pretending it is irrelevant. Eli Lilly's lepodisiran is running the same deep-reduction experiment, so the hypothesis will be tested with or without Amgen.
Amgen is not an Lp(a) pure-play. MariTide in obesity, Repatha in cholesterol, and Tezspire in asthma drive more value for the company, and this diversification creates a cushion for the stock, although the selloff ultimately became much larger than the initial 5% after-hours reaction. Positioning has stayed calm since the beginning of 2026. Insider Monkey data shows 66 hedge funds held AMGN in the second quarter of 2026, up slightly from 65 in the first. Short interest, on the other hand, sits at just 2.4% of float, reflecting minimal bets against the stock in the market.

#horizon #pelacarsen

Hewlett Packard Enterprise Company (NYSE:HPE) announced an expanded collaboration with Oracle Corporation (NYSE:ORCL) on September 2 to scale Oracle's global AI infrastructure using HPE Juniper Networking across Oracle Cloud Infrastructure (OCI) data centers. The partnership builds on over a decade of joint engineering, leveraging HPE's routing and switching platforms to support OCI's expanding gigawatt-scale GPU superclusters. To align long-term incentives, HPE issued stock warrants to Oracle.
Following the announcement, Wall Street delivered fast price target hikes: Barclays' Tim Long raised HPE's target by $12 to $79 (Overweight), citing server upside and robust margins, while Morgan Stanley's Sanjit Singh boosted Oracle's target by $3 to $210 (Equal Weight), noting a tactically positive setup driven by GPUaaS demand.
Hewlett Packard Enterprise Company (NYSE:HPE) and Oracle both delivered strong results, although Oracle operates at a significantly larger scale. HPE reported record Q3 2026 revenue of $12.2 billion, up 34% year over year, driven by strong server demand and a 74.9% increase in Networking revenue to $2.9 billion. GAAP diluted EPS reached $1.06, while strong execution led management to raise full-year FY26 revenue growth guidance to 34%-37% and its free cash flow target to at least $3.75 billion.
Oracle Corporation (NYSE:ORCL), meanwhile, ended fiscal 2026 with record Q4 revenue of $19.2 billion, up 21% year over year, and full-year revenue of $67.4 billion, up 17%. Q4 Cloud Infrastructure (IaaS) revenue surged 93% to $5.8 billion, while full-year GAAP EPS rose 34% to $5.83 and Remaining Performance Obligations (RPO) jumped 363% to $638 billion.
Overall, ORCL leads in hyper-growth and long-term backlog, reinforcing its position as the stronger software and cloud play, while HPE is demonstrating stronger near-term hardware momentum and attractive cash flow generation for value-oriented investors.

#billion #revenue #infrastructure

Updated Sept 03, 2026, 12:47 pm EDT / Original Sept 03, 2026, 11:10 am EDT
Moderna
MRNA
-2.23%
has received its second Sell rating on Wall Street, but the downgrade has little to do with the drugmaker’s commercial potential or pipeline prospects.
MRNA
-2.23%
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

#sept #moderna #sell #street

Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below.
You might have more in common with billionaires than you think.
"It's funny, talking about my personal finances, because no one ever believes anything I say," said YouTube creator Jimmy Donaldson, more well-known as MrBeast, to the Wall Street Journal earlier this year (1). "I have negative money right now, I'm borrowing money. That's how little money I have."
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one
JPMorgan sees gold hitting $5,000/oz by Q4 — and savvy investors are protecting their wealth with a tax-advantaged Gold IRA. Get your free guide from Priority Gold

#Gold #jimmy

Houston, Texas-based Chevron Corporation (CVX) is one of the world's largest integrated energy companies, with operations spanning oil and natural gas exploration and production, refining, marketing, chemicals, and lower-carbon energy. Headquartered in Houston, Texas, Chevron operates across the U.S. and numerous international markets. The company has a market cap of $364.5 billion.
Companies with a market capitalization of $200 billion or more are typically referred to as "mega-cap stocks." CVX fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the integrated oil and gas industry. A major strength of Chevron is its vertically integrated and geographically diversified portfolio. The upstream business provides significant exposure to oil and gas prices, while refining, marketing and chemicals operations can provide earnings diversification when commodity prices or refining margins move in different directions.
Wu-Tang Clan Member Raekwon Is a Palantir 'OG,' Visiting Headquarters 16 Years After Receiving His Custom PLTR Jacket
Tesla Stock Could Benefit as Trump Locks Down the U.S. Power Grid
Tesla Just Killed Its Solar Roof After Years of Struggling to Scale. What It Means for TSLA Stock.

#market #texas #Stock

Biotech stocks had already been gaining ground before this week's news. In June, the iShares Nasdaq Biotechnology ETF (IBB) traded just 1.47% below its 52-week high after moving sideways since November.
Then, Moderna (MRNA) surged more than 176%, while Merck (MRK) gained over 12%, after their personalized mRNA cancer vaccine reduced melanoma recurrence in a late-stage trial. The INTerpath-001 study included 1,137 high-risk melanoma patients and delivered the first successful Phase 3 result for an individualized mRNA neoantigen therapy.
Soros Fund Management Opened a New Position in Nebius During Q2. What This Means for NBIS Stock.
Nvidia Earnings, Jackson Hole and Other Key Things to Watch this Week
Ahead of Nvidia Earnings, Here's What Barchart Data Says Comes Next for NVDA Stock

#week #Biotech #june #NASDAQ

D.R. Horton's cancellation rate hit 20% on qualification failures, and loanDepot has collapsed 59% year to date as mortgage origination dries up.
Annaly Capital rose 12% as higher MBS yields widened its net interest spread, while PNC jumped 25% repositioning its portfolio to a 4.4% yield.
The 10-year Treasury, not the Fed, sets mortgage rates, and with CPI at 3.4% and the 10-year near 12-month highs, borrower relief looks distant.
Act now: the ***** yst who called NVIDIA in 2010 just named his top 10 AI stocks — and DR Horton didn't make the cut. Grab the names FREE today.
The buyer sitting in a D.R. Horton (NYSE:DHI) sales office in suburban Dallas this week is looking at a 30-year fixed mortgage of 6.67% on the Freddie Mac Primary Mortgage Market Survey for the week ending August 13, 2026, and 6.75% on Mortgage News Daily's Tuesday reading. In late February, the Freddie Mac number was 5.98%. In the interim, the Federal Reserve did nothing. Chair Kevin Warsh has held the federal funds target at 3.75% for 231 consecutive days. Your mortgage rate went up anyway.

#horton #rate

Aug 13, 2026, 5:48 pm EDT
Recent quarterly results at private credit firms seem to have reassured investors, and the shares of some listed credit funds are up 10% this month. That’s even true for Blue Owl Technology Finance
OTF
-0.35%
, a $15 billion fund focused on lending to the sort of tech companies that are giving Wall Street the night frights.
OTF
-0.35%
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

#recent #blue #finance

Jim Cramer has spent months giving mixed signals on Axon Enterprise, Inc. (NASDAQ:AXON). While he regularly praises the company's law enforcement products, he has repeatedly warned that the stock costs too much. That caution finally turned into a pass during the August 6 episode of Mad Money when a caller asked about buying the post-earnings pullback:
No, no, I don't want to touch it. It's only down 8%, but it's been an amazing performance for so many years. The stock's had too big a run; I want to move elsewhere.
Before telling investors to look elsewhere in August, Cramer had flagged valuation and competitive friction earlier in the year. During the May 15 episode of Mad Money, a caller asked about a long-term position held since 2015. While acknowledging a strong management presentation that lifted the shares that day, Cramer pointed to lingering hurdles:
Well, they had, you know, Axon was on today. I thought they acquitted themselves, which is why I think why the stock was up three bucks. I have been, we were very worried about Motorola competition when we met with them when we were up at Harvard Business School. I am still concerned about that, and I still think that this market does not like high multiple stocks, and Axon is a high multiple stock.
Cramer expanded on that valuation tension during the June 3 episode. When a shareholder asked whether to buy more, sell, or hold, he advised maintaining the existing position strictly on product quality, while warning that the price-to-earnings multiple left little room for error:

#money #caller

By
Aug. 5, 2026 8:03 am ET
Listen
(1 min)
Dine Brands recorded higher sales and lower profit in the second quarter, as IHOP’s growth helped offset a decline at Applebee’s.

#applebee #profit

Access to this page has been denied because we believe you are using automation tools to browse the website.
This may happen as a result of the following:
Please make sure that Javascript and cookies are enabled on your browser and that you are not blocking them from loading.
Reference ID: #1f46afdb -9140-11f1-91b2-e4c265c27ca2

#please #reference #page

Corning (GLW), best known to many investors as the maker of Gorilla Glass, had increasingly been revalued as an important supplier to the AI buildout thanks to its optical connectivity business. However, its latest earnings shock is a reminder that even the market's most celebrated AI infrastructure winners can run into gravity when expectations get too high.
Its shares fell as much as 20% intraday on July 28 after the company reported second-quarter results. That is one of the sharpest single-day declines in years for a name that had become a high-conviction proxy for AI infrastructure spending.
CoreWeave Just Scored a Leidos Partnership. What That Means for CRWV Stock Here.
Palantir Is Set to Deliver Strong Q2. ******* ysts See 60% Upside Potential for PLTR Stock.
Earnings, PMI and Other Key Things to Watch this Week

#infrastructure #gorilla

O'Keeffe Stevens Advisory, an investment advisory firm, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. During Q2 2026, the market experienced notable dispersion between perceived AI losers and winners. The firm has made investments early in AI infrastructure companies, which yielded gains during market repricing. The second quarter experienced strong equity rallies, with the S&P 500 gaining 15.2% and the Nasdaq 21.4%, marking the best quarter since Q2 2020. While the software sector faced challenges, with the iShares Software ETF dropping ~27% before a rally, reflecting high volatility. This volatility is seen as an opportunity, despite the potential for 'dead money' in underperforming stocks. The firm remains cautious, focuses on owning durable businesses at reasonable prices, holding cash, and hedging risks to navigate unpredictability. In addition, please check the Strategy's top five holdings to know its best picks in 2026.
In its Q2 2026 investor letter, O'Keeffe Stevens Advisory highlighted Warrior Met Coal, Inc. (NYSE:HCC). Warrior Met Coal, Inc. (NYSE:HCC) is a non-thermal metallurgical coal producer. On July 27, 2026, Warrior Met Coal, Inc. (NYSE:HCC) stock closed at $80.66 per share. One-month return of Warrior Met Coal, Inc. (NYSE:HCC) was -0.62%, and its shares gained 52.30% over the past 52 weeks. Warrior Met Coal, Inc. (NYSE:HCC) has a market capitalization of $4.26 billion.
O'Keeffe Stevens Advisory stated the following regarding Warrior Met Coal, Inc. (NYSE:HCC) in its Q2 2026 investor update:
"Warrior Met Coal, Inc. (NYSE:HCC): Unsurprisingly, a commodity-producing company's stock experienced Signiant volatility during the quarter. Had the quarter ended one month prior, it's possible we would have been talking about Warrior as a top performer during the quarter. On May 23, 2026, a gas explosion at a coal mine in Shanxi province killed 82 workers, making it China's deadliest coal mining accident since at least 2009. The blast occurred at the privately owned Liushenyu mine in the coal-belt region of Shanxi, and a deadly gas explosion occurred at the Liushenyu Coal Mine in Qinyuan county with 247 workers underground; all four coal mines under Tongzhou Group suspended operations following the incident, driving met coal prices higher. Blue Creek remains the next leg of the story. Increasing production and sales volume at this mine should drive revenue and EPS growth, even in the face of an overall weaker met coal pricing environment."

#coal #stevens #firm

Jamie Dimon is getting more bearish on the stock market.
The CEO of JPMorgan Chase (NYSE:JPM) and one of the most influential voices in finance says he would not buy either stocks or U. S. Treasuries at current prices. And investors, he added, are ignoring some significant threats to the market.
Jeff Bezos backs a platform that lets anyone invest in rental homes for as little as $100 — 6 ways to build wealth like a landlord without actually being one
Dave Ramsey warns nearly 50% of Americans are making 1 big Social Security mistake — here's what it is and 3 simple steps to fix it ASAP
Millionaires under 43 hold only 25% of their wealth in stocks. Here's where their money is actually going

#stocks

The stock market took a beating this week as the major AI and chipmaking names dropped. Having propped up the market for months — even years — the AI industry dragged it down this past week.
However, that didn't stop these five companies from showing resilience.
Payments player Flywire got a boost from an offer to acquire its competitor PayPal. International Seaways gained on the back of renewed tensions in the Middle East. Snowflake (SNOW) is among a handful of software names standing out.
The trucking juggernaut J.B. Hunt continued its superb run this year with strong earnings. In addition to its own individual successes, investors could consider J.B. Hunt the quintessential "HALO trade" stock, used to hedge against AI.
Finally, chip-gear maker ASML largely bucked the AI sell-off on strong earnings and guidance.

Equinix (NASDAQ: EQIX) said Wednesday that Chief Business Officer Jon Lin will separate from the data center operator effective July 18. The company made the filing on Tuesday with the Securities and Exchange Commission.
The filing lists July 8 as the earliest reported event date. Equinix will distribute Lin's responsibilities among its senior leadership team under a transition plan.
The company anticipates revealing a new chief product officer soon but did not identify the incoming executive. The filing did not name a replacement for Lin as chief business officer.
Lin joined Equinix in 2009 as director of innovation. Equinix promoted him to executive vice president and general manager of data center services in January 2022 after he served as president of the Americas.
Equinix previously credited Lin with helping develop Equinix Cloud Exchange, later renamed Equinix Fabric. He also helped lead the $3.6 billion acquisition of 29 Verizon data centers in 2017.

PowerFleet, Inc. (NASDAQ:AIOT) is one of the 10 Fastest Growing Tech Penny Stocks to Buy.
On July 1, 2026, PowerFleet, Inc. (NASDAQ:AIOT) announced the Australian launch of SafeGuard, an AI-powered risk intelligence solution for on-road driver behavior. Available as an add-on to Powerfleet's VisionAI video solution and integrated within the Unity platform, SafeGuard uses artificial intelligence to ****** s driver risk across a fleet and help safety teams focus on events and behaviors most likely to lead to incidents. Brodie von Berg, Managing Director, Powerfleet APAC, said SafeGuard helps teams identify the "highest-risk drivers and behaviours" in real time, supporting earlier intervention and coaching.
Powerfleet said SafeGuard combines real-time risk monitoring, AI-powered driving risk ****** ysis, intelligent video event review, and live intervention capabilities. Operators using SafeGuard have reported up to 83% reduction in on-road risk, 95% fewer false positive video event alerts, and an 80% reduction in video review time.
Image by aymane jdidi from Pixabay
Also on July 1, PowerFleet announced that its Board of Directors approved a stock repurchase program authorizing the company to repurchase up to $30M of common stock over the next 24 months. On June 16, Raymond James lowered the firm's price target on PowerFleet to $7 from $8 and kept an Outperform rating on the shares. Raymond James said Q4 results came in ahead of expectations, with an improved FY27 outlook reflecting accelerating growth and profitability into year-end.

We recently published Jim Cramer Insisted Recent AI Chip Selloff Wasn't A Bottom & Discussed These 17 Stocks. The Boeing Company (NYSE:BA) is one of the stocks discussed by Jim Cramer.
Aerospace giant The Boeing Company (NYSE:BA)'s shares are up by 4.2% over the past year and are flat year-to-date. Jefferies and Wells Fargo discussed the firm in early June. The former reiterated a $295 share price target and a Buy rating on the stock, while the latter kept an Overweight rating and a $250 share price target. Cramer has been one of The Boeing Company (NYSE:BA)'s strongest supporters and has kept the faith in the firm during its tumultuous times. In 2025, he was one of the first to suggest that the company's cash flows under CEO Kelly Ortberg might be improving after it had suffered from production slowdowns following the FAA's orders. The CNBC TV host has praised Ortberg on multiple occasions, and this time, he commented on The Boeing Company (NYSE:BA)'s recent share price performance:
"Impressive catch-up move by Boeing after big run in airlines. Honeywell Aerospace starting its take-off.
"With Boeing and GE Aerospace taking off it might be worth it to buy some HONA which reversed after a very good run. All three are pure play aero but HONA has the most upside imo"
Jirat Teparaksa/Shutterstock.com

Strategy's (NASDAQ: $MSTR) recent Bitcoin (CRYPTO: $BTC) sales are not the main risk facing the cryptocurrency or the market for digital **** ets, says JPMorgan Chase (NYSE: $JPM).
Analysts at the largest U.S. bank say that the bigger threat to the cryptocurrency market comes from adoption that does not benefit public blockchains and their tokens.
Nikolaos Panigirtzoglou, the lead crypto **** yst at JPMorgan, said in a new report that the crypto ecosystem could see slower activity, lower liquidity, and weaker capital flows as tokenization, payments, and settlement increasingly happen outside public crypto networks.
More From Cryptoprowl:
Ripple, The Company Behind XRP, Is Valued At $50 Billion

August Nymex natural gas (NGQ26) on Wednesday closed down -0.053 (-1.62%).
Nat-gas prices on Wednesday fell from a 1.5-week high and settled lower on the outlook for a larger-than-normal increase in weekly US domestic stockpiles, which are already above the five-year average. The consensus is that Thursday's weekly EIA nat-gas inventories will increase by +61 bcf for the week ended July 3, above the five-year average for the week at +51 bcf.
Crude Oil Prices Jump as Ships Attacked in the Strait of Hormuz
Crude Oil Prices Sharply Higher on Supply Disruptions
Nat-Gas Prices Climb on Carryover Support from European Nat-Gas